Objectives: Upon completion of this article, the reader will be able to describe variceal pathophysiology and conventional management, discuss current and emerging transjugular intrahepatic portosystemic shunt (TIPS) indications, identify TIPS clinical outcomes, and explain the role of adjuvant embolotherapy.Accreditation: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Tufts University School of Medicine (TUSM) and Thieme Medical Publishers, New York. TUSM is accredited by the ACCME to provide continuing medical education for physicians.Credit: Tufts University School of Medicine designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.Variceal hemorrhage is a catastrophic consequence of portal hypertension and a leading cause of death among cirrhotic patients. Management of this condition requires a multidisciplinary approach that emphasizes early detection and encompasses pharmacologic, endoscopic, surgical, and image-guided interventional therapies. This review focuses on the role of the transjugular intrahepatic portosystemic shunt (TIPS) procedure in the context of variceal hemorrhage, with emphasis on variceal pathophysiology and conventional management, current and emerging TIPS indications, TIPS clinical outcomes, and the role of adjuvant embolotherapy.
Variceal Hemorrhage Pathophysiology and EpidemiologyThe hyperdynamic circulation and portal venous congestion attendant to longstanding liver cirrhosis contribute to the formation of esophageal and gastric varices, particularly in the presence of a hepatic venous pressure gradient exceeding 10 mm Hg. 1 Roughly 30 to 40% of compensated cirrhotic patients and 60% of decompensated cirrhotic patients present with esophageal varices at the time of diagnosis. 2 Gastric varices are less common, occurring in roughly 20% of patients with portal hypertension, but are associated with more
AbstractVariceal hemorrhage is a life-threatening complication of cirrhosis that requires a multidisciplinary approach to management. The transjugular intrahepatic portosystemic shunt (TIPS) procedure is a minimally invasive image-guided intervention used for secondary prevention of bleeding and as salvage therapy in acute hemorrhage. This review focuses on the role of TIPS in the setting of variceal hemorrhage, with emphasis on the pathophysiology and conventional management of variceal hemorrhage, current and emerging indications for TIPS creation, TIPS clinical outcomes, and the role of adjuvant embolotherapy.